Lonza - PBMCs

EDITORIAL SECTION

KNOWLEDGE BANK

  • Articles

    Mass Spectrometers: Principles, Instrumentation, Applications, and Future Perspectives

    Mass spectrometry MS is one of the most powerful analytical technologies available in modern science It enables the identification characterization and quantification of compounds based on their masstocharge ratio mz Since its development in the early twentieth century mass spectrometry has evolved from a basic analytical tool into a sophisticated technology capable of studying highly complex biol...

TOP ARTICLES

press releasesRead more...

Etcamah in combination with a CDK4/6 inhibitor approved in the US for 1st-line advanced HR-positive breast cancer

AstraZenecas Etcamah camizestrant in combination with a cyclindependent kinase CDK inhibitor abemaciclib palbociclib or ribociclib has been approved in the US for the treatment of adult patients

Cipla Announces Exclusive Partnership with Qilu Pharmaceutical for the Licensing and Supply of Biosimilar to Keytruda® (Pembrolizumab) in the US FacebookPinterest

Invagen Pharmaceuticals Inc a wholly owned subsidiary of Cipla Limited BSE NSE CIPLA today announced that it has entered into a strategic partnership with Qilu Pharmaceutical Co Ltd

Fresenius Kabi Launches Generic Sugammadex in Simplist® Ready‑to‑Administer Prefilled Syringe in the U.S.

Fresenius Kabi a global healthcare company part of the Fresenius Group specializing in lifesaving therapies and technologies today announced the US launch of the FDAapproved generic Sugammadex

Lōkahi Therapeutics™ Expands ai² Futures Lab™ Asset Origination Network Through Continued Collaboration with the University of Georgia

Lkahi Therapeutics a subsidiary of Glucotrack Inc Nasdaq GCTK today announced the continued participation of the University of Georgias Student Industry Fellows Program in the ai Futures Lab

03 - 05

Sep 2026

5th MENA Congress for Rare Diseases 2026

Beach Rotana Hotel, Abu Dhabi,...

09 - 10

Sep 2026

iPSC Drug Development Summit

Hyatt Regency Boston Harbour,...

14 - 15

Sep 2026

16th American DDF Summit

Omni Boston Hotel at the Seapo...

15 - 17

Sep 2026

COPD Drug Development Summit 2026

Street, Boston, MA 02210, USA

21 - 23

Sep 2026

21 - 23

Sep 2026

Cancer R&D World Conference

Hilton Garden Inn Miami Dolphi...

22 - 23

Sep 2026

LATEST NEWSRead more...

Lupin receives US FDA approval for Modafinil tablets

Lupin has received approval from the US Food and Drug Administration FDA for its Abbreviated New Drug Application ANDA for Modafinil Tablets USP mg and mg

AtomVie opens new radiopharmaceutical manufacturing facility in Ontario

AtomVie Global Radiopharma AtomVie a contract development and manufacturing organisation CDMO specialising in radiopharmaceuticals has opened a new manufacturing facility in Hamilton Ontario

FDA Approves First Drug to Treat Alexander Disease

The US Food and Drug Administration FDA has approved Zanvastro zilganersen injection for the treatment of Alexander disease in paediatric and adult patients It is the first FDAapproved treatment

AbbVie Completes Acquisition of Apogee Therapeutics

AbbVie has completed its acquisition of Apogee Therapeutics bringing the biotechnology company and its pipeline of antibodybased treatments into AbbVie

EpiVax Launches AI-Enhanced Models for Immunogenicity Prediction

EpiVax Inc has launched AIenhanced features for ISPRI its in silico platform for assessing the immunogenicity risk of biotherapeutics The update includes an improved JanusMatrix model

Thermo Fisher Scientific Launches Multiskan™ Ease Absorbance Microplate Reader

Thermo Fisher Scientific has launched the Thermo Scientific Multiskan Ease Absorbance Microplate Reader designed to simplify routine laboratory analysis involving proteins cells and microorganisms